Circulating Tumor DNA (ctDNA) Monitoring in the Assessment and Prediction of the Efficacy of PARP Inhibitors (PARPi)
RecruitingOBSERVATIONAL
Enrollment
30
Participants
Timeline
Start Date
October 31, 2021
Primary Completion Date
March 31, 2023
Study Completion Date
August 31, 2025
Conditions
Metastatic Castration-resistant Prostate Cancer
Trial Locations (1)
510060
RECRUITING
Sun Yat-sen University Cancer Center, Guangzhou
All Listed Sponsors
lead
Sun Yat-sen University
OTHER
NCT05116579 - Circulating Tumor DNA (ctDNA) Monitoring in the Assessment and Prediction of the Efficacy of PARP Inhibitors (PARPi) | Biotech Hunter | Biotech Hunter